CCO Oncology Podcast

Role of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities

Episode Summary

Description: A brief 1-2 sentences that summarizes the content. It is displayed on the activity page and podcast channel page. This should not mention certification of the activity. Include faculty names whenever possible for promotional name recognition and improved searchability. Include the SEO Primary Keyword/Keyword Phrase. Listen to Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of the multidisciplinary team in achieving comprehensive and individualized care of patients with HR-positive/HER2-negative metastatic breast cancer and preexisting comorbidities.

Episode Notes

In this podcast episode, Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of the multidisciplinary team in achieving comprehensive and individualized care of patients with HR-positive/HER2-negative metastatic breast cancer and preexisting comorbidities, including:

• Key Comorbidities in Patients with HR+/HER2- MBC
• Impact of Polypharmacy
• Role of APPs in Comprehensive Care
• Role of CDK4/6 Inhibitors and Other Treatments for HR+/HER2- MBC
• Utility of RWE data
• Communicating Treatment Options With Patients and Caregivers
• Understanding Patient Goals and Coordinating With the Multidisciplinary Team to Individualize Treatment and Maximize Quality of Life

Link to full program:
https://bit.ly/4jCQe38